China’s largest venture capital houses are tapping the market for at least $2 billion in new funds, re-engaging with the ...

This week’s Bulls N’ Bears ASX Runners of the Week is… Lumos Diagnostics, after the company signed an exclusive diagnostics ...

The amount raised via follow-on offerings reaches US$31.4 billion in the first half of 2025, outpacing all of 2024.

Hong Kong’s property slump is weighing on a range of local developers, with a well-known but smaller-scale builder the latest to seek relief from creditors.

Weeks after a capital raise that valued the company at more than $6 billion, Airwallex has become Arsenal’s official finance ...

Foreign investors are returning to China in search of opportunities in artificial intelligence startups, including those in ...

The U.S. FDA’s Oncologic Drugs Advisory Committee took up the matter of GSK plc’s relapsed/refractory multiple myeloma drug, Blenrep (belantamab mafodotin). A B-cell maturation antigen-directed ...

NTT DC REIT’s IPO was supposed to be a shot in the arm for Singapore’s flagging equity market, decried by analysts as “lackluster” due to its lack of growth stocks and tiny number of listings. NTT’s ...

Biel Crystal Manufactory Ltd., one of the world’s largest producers of glass covers for phones, is considering reviving its ...

Hong Kong's initial public offering market is gaining depth and dynamism and reinforcing its role as a premier global listing ...

Thirty-six biotechnology, pharmaceutical and medical device companies sought a capital raise on the Hong Kong Stock Exchange in the first half (H1) of 2025, a review by BioWorld found. Of those, 34 ...